Sargenti Opposition Society

Sargenti Opposition Society
WHAT YOUR DENTIST MAY NOT TELL YOU
but you need to know before your next root canal

Injured patients should file an adverse event report with the FDA. Absent reports from the public, the FDA will not realize the extent of the dangers of Sargent Paste. Click here to file report. Also ask your doctor to file a report on your behalf. Since reports are voluntary over 90% of adverse events go unreported.

LEGAL AND ETHICAL RESEARCH

*NEW* Australia. The Root of the Problem, Dr Roger Dennett, DDAS, ADA (NSW), Australian Dento-Legal Review 2009.
A review of the endodontic paraesthesia literature reveals that most cases have resulted from overfill of a paraformaldehyde paste into the vicinity of the mental or inferior alveolar nerves. A literature review supports the contention that paraformaldehyde containing pastes not be used to root fill mandibular molars and premolars. Sealers that contain both eugenol and paraformaldehyde, such as Endomethasone and N2, were found to be the most toxic.

US. Ethics versus Legal Informed Consent - A Distinction with Little Difference, Zinman, E., Journal of the History of Dentistry, vol. 55, no. 3 Winter 2008. www.toothattorney.com

US. Flordia Administrative Code, Department of Health, Board of Dentistry, Dental Practice and Principles, Rule: 54B5-17012, Notice ID 2394268

US. Combating Dubious Dental Practice, H. Jeffrey Orbach, DDS, MS

Health Fraud - "Promotion of an unproven product for profit" - FDA definition
Quackery - "The promotion of a false or unproven method for profit" - National Council Against Health Fraud
Quack - To advertise or sell with fraudulent claims - Random House Unabridged Dictionary of the English Dictionary
Dubious Dental Practice - Sargenti Root Canal Therapy
Scientific Method vs. Testimonials
- Testimonials lack scientific credibility regardless of their source.
- Often used in lieu of credible science
- Number of endorsements and reputation of endorser are not replacements for good science
Does a Treatment Method Work? - If there is a question about safety, does the potential benefit exceed the likelihood of harm?

US. Food and Drug Law, N2 Universal: A Case Study of An NDA, Lisa Barr, January 27, 1994, 803-8543-9

It is the policy of the Sargenti Opposition Society to post only the most current and verified information obtained from credible sources. If you have documentation that conflicts with any information on our site or demonstrates a violation of any type, please contact us and we will correct our site as necessary.